Monday, 23 September 2019

Vaccines News

  • China's Sinovac progresses to launch new vaccines

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2015

    Singapore: China's biopharmaceutical firm, Sinovac Biotech, is progressing on its pipeline vaccines and expects to bring the much needed vaccines for infectious diseases in the market soon....Read more

  • No proof of human-to-human H7N9 infection'

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 06 Feb, 2014

    Singapore: Amid fears of H7N9 turning into a pandemic in China with a new bout of cases, the country's National Health and Family Planning Commission released in a reassuring statement. Th...Read more

  • Tourists to soon get vaccine for 'Delhi Belly', typhoid

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2013

    Singapore: Researchers at the University of Cambridge, UK, are developing a vaccine that would prevent bad stomach (or Delhi Belly as it is popularly called) or typhoid in tourists during v...Read more

  • Takeda expands Singapore operation

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 26 Feb, 2015

    Singapore: Japan headquartered Takeda Pharmaceutical has expanded its operations in Singapore in order to focus on emerging markets and to consolidate and streamline its Asia operations. D...Read more

  • Dengue incurs annual cost of $950 mn to SE Asia

    Vaccines |  Analysis | By BioSpectrum Bureau  | 0 Comment | 20 Jun, 2014

    Philippines: The economic burden churned by mosquito borne disease, dengue, is costing upto $950 million to south east Asian countries every year and the countries are in desperate stage to...Read more

  • Ebola cure depends on biotech drug ZMapp

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 07 Aug, 2014

    Strange as it may sound, the dreaded tobacco plant blamed for millions of deaths of cigarette smokers could emerge as the savior in producing the only working cure against Ebola. A small Am...Read more

  • EU reviews Sanofi's 4-in-1 Influenza vaccine

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 12 Apr, 2013

    Singapore: Sanofi Pasteur has been accepted for review in the European Union for a quadrivalent (four-strain) formulation of Vaxigrip. The file has been accepted for review by France's Agen...Read more

  • Admedus increases share in Ian Frazer vaccine tech

    Vaccines |  News | By BioSpectrum Bureau  | 2 Comment | 24 Jul, 2014

    Singapore: Australia's healthcare company focused on investing in and developing next generation technologies, Admedus, has increased its ownership in Admedus Vaccines, the platform vaccine...Read more

  • Are declining Ebola cases a challenge for clinical studies?

    Vaccines |  Analysis | By BioSpectrum Bureau  | 0 Comment | 16 Mar, 2015

    Singapore: The steady decline in new ebola cases presents a formidable challenge to current and future clinical trials of investigational treatments for the disease, as it will be more diff...Read more

  • BMS releases $3.5 mn fund for Hep B&C in India, China

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 04 Dec, 2014

    Singapore: Bristol-Myers-Squibb Foundation has released nine new grants totaling to around $3.5 million towards hepatitis B virus (HBV) and hepatitis C virus (HCV) in India and China. The ...Read more

  • SII seeks WHO consent to export flu vaccines

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 12 Dec, 2012

    Singapore: Serum Institute of India (SII) has applied for permits to export flu vaccines produced using Australia's BioDiem's proprietary technology. The permit is applied with the World H...Read more

  • Vaccine must to curb AIDS

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 23 Feb, 2015

    Singapore: In a recent conference organized by the International AIDS Vaccine Institute, experts said that though the world has made considerable progress in curbing AIDS it was important t...Read more

  • Italy clears Novartis seasonal influenza vaccines

    Vaccines |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 14 Nov, 2012

    Singapore: The Italian Medicines Agency (AIFA) has lifted the temporary halt on the use of Agrippal and Fluad vaccines in Italy. The decision follows additional information provided by the ...Read more

  • Bridge to the DNA vaccine dream

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jun, 2012

    Can DNA vaccines be the answer to diseases such as malaria and influenza? Though DNA-based vaccines have emerged as appealing alternatives to conventional ones, there are still gaps to be f...Read more

  • Vaccine delivery technologies of the future

    Vaccines |  Analysis | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2012

    Respiratory syncytial virus (RSV), a disease that causes infections of the lower respiratory tract mostly in infants and children, claims lives of nearly 200,000 children every year. Nearly...Read more

  • Polio vac mandatory for travelers from 7 nations: India

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 05 Mar, 2014

    Singapore: All travelers coming from these countries to India would need to take OPV six weeks before departure from their country. Polio vaccine will also be administered to all travelers ...Read more

  • New malaria vaccine produced from algae

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 19 Feb, 2015

    Singapore: US researchers have developed a new candidate vaccine for malaria from algae. In a study, published in the journal Infection and Immunity, scientists elaborated that paired with ...Read more

  • No vaccination, No benefits, says Australian PM

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 21 Apr, 2015

    Singapore: Australian government has recently made an announcement that parents who refuse to vaccinate their children may lose up to AUD$11,000 worth welfare benefits a year. The new polic...Read more



Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls